Sodium-glucose cotransporter-specific substrate αMG stimulates endogenous glucagon secretion and ameliorates obesity-associated metabolic disorders in mice

Key Points

• The research aims to investigate the effects of αMG on glucagon secretion and its potential benefits for obesity-related metabolic disorders.
• Administration of αMG to mice
• Measurement of glucagon levels
• Evaluation of metabolic parameters
• αMG significantly increased endogenous glucagon secretion
• Improvement in metabolic disorders associated with obesity observed
• Potential therapeutic benefits for obesity-related conditions suggested